SRC (P12931) variants and mutations
SRC (also known as P12931) is a human protein-coding gene encoding a proto-oncogene tyrosine-protein kinase protein. It integrates signals from growth-factor receptors, integrins, and other surface proteins to regulate proliferation, adhesion, migration, and survival. Persistent SRC-family signaling promotes invasion and therapy resistance in many cancers and remains an important therapeutic target. This analysis covers 1,057 SRC variants and mutations. Of these, 67% have computational variant effect predictions. Disease context includes cancer, chronic myelogenous leukemia, BCR-ABL1 positive, and actinic keratosis. Example SRC variants include M1?, G2D, and G2C.
Variant analysis overview
- Gene: SRC
- Protein: P12931
- UniProt accession: P12931
- Organism: Homo sapiens
- Variants analyzed: 1057
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 754 unspecified-consequence records; 174 missense variants; 87 synonymous variants; 9 stop-gained variants; 23 frameshift variants; 1 in-frame deletions; 2 in-frame insertions; 1 splice-region variants; 6 substitution
- Prediction scores: 704 variants have prediction scores (67% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: cancer, chronic myelogenous leukemia, BCR-ABL1 positive, actinic keratosis, acute lymphoblastic leukemia, medullary thyroid gland carcinoma, Noonan syndrome, neoplasm, Costello syndrome, Rare hemorrhagic disorder due to a constitutional platelet anomaly, hypertrophic cardiomyopathy, non-small cell lung carcinoma, listeriosis.
Protein structure and variant hotspots
- Protein features: 3 domains; 2 binding sites; 6 post-translational modification sites.
- Structural context: 532 variants have structural context.
- PTM context: 15 variants overlap post-translational modification sites.
- Experimental data: 57 protein positions have experimental scores. Source: SRC SH3 domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SRC variants
Examples include M1?, G2D, G2C, G2V, G2G, S3C, S3R, S3T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10065, Variant assessed as somatic; high impact.
- G2D (p.Gly2Asp), cosmic curated COSV62440, Ensembl rs2147049044
- G2C (p.Gly2Cys), gnomAD 20-37384157-G-T, REVEL 0.57, MetaLR 0.53
- G2V (p.Gly2Val), gnomAD 20-37384158-G-T, REVEL 0.62, MetaLR 0.53
- G2G (p.Gly2Gly), rs2070408230, gnomAD 20-37384159-T-C, CADD 14.50
- S3C (p.Ser3Cys), cosmic curated COSV62439
- S3R (p.Ser3Arg), Ensembl rs2147049074, REVEL 0.10, CADD 23.80
- S3T (p.Ser3Thr), ExAC rs767602518, gnomAD rs767602518, REVEL 0.20, CADD 22.60
- S3G (p.Ser3Gly), gnomAD 20-37384160-A-G, REVEL 0.19, MetaLR 0.19
- S3I (p.Ser3Ile), gnomAD 20-37384161-G-T, REVEL 0.21, MetaLR 0.24
- S3N (p.Ser3Asn), gnomAD 20-37384161-G-A, REVEL 0.17, MetaLR 0.24
- S3S (p.Ser3Ser), gnomAD 20-37384162-C-T, CADD 14.90
- N4H (p.Asn4His), gnomAD rs1320051629, REVEL 0.16, CADD 22.20
- N4Y (p.Asn4Tyr), gnomAD 20-37384163-A-T, REVEL 0.14, MetaLR 0.18
- N4D (p.Asn4Asp), gnomAD 20-37384163-A-G, REVEL 0.15, MetaLR 0.19
- N4N (p.Asn4Asn), rs367543237, gnomAD 20-37384165-C-T, CADD 13.20
- K5N (p.Lys5Asn), gnomAD rs1262407930, REVEL 0.28, CADD 25.40
- K5R (p.Lys5Arg), TOPMed rs2070408441, gnomAD rs2070408441, REVEL 0.32, CADD 31.00
- K5E (p.Lys5Glu), gnomAD 20-37384166-A-G, REVEL 0.41, MetaLR 0.46
- K5* (p.Lys5Ter), gnomAD 20-37384166-A-T, CADD 38.00
- S6N (p.Ser6Asn), NCI-TCGA Cosmic COSV6244, cosmic curated COSV62441, Ensembl rs2147049141, Variant assessed as somatic; moderate impact.
- S6R (p.Ser6Arg), Ensembl rs2147049153
- S6I (p.Ser6Ile), gnomAD 20-37384170-G-T, REVEL 0.52, MetaLR 0.48
- S6S (p.Ser6Ser), rs2147049153, gnomAD 20-37384171-C-T, CADD 14.80
- K7R (p.Lys7Arg), gnomAD 20-37384173-A-G, REVEL 0.39, MetaLR 0.47
- K7K (p.Lys7Lys), gnomAD 20-37384174-G-A, CADD 13.50
- K7N (p.Lys7Asn), gnomAD 20-37384174-G-T, REVEL 0.39, MetaLR 0.46
- P8T (p.Pro8Thr), Ensembl rs2070408606, REVEL 0.29, CADD 22.40
- P8S (p.Pro8Ser), gnomAD 20-37384175-C-T, REVEL 0.26, MetaLR 0.26
- P8L (p.Pro8Leu), gnomAD 20-37384176-C-T, REVEL 0.35, MetaLR 0.29
- P8H (p.Pro8His), gnomAD 20-37384176-C-A, REVEL 0.37, MetaLR 0.37
- P8P (p.Pro8Pro), rs1329691407, gnomAD 20-37384177-C-T, CADD 14.80
- K9T (p.Lys9Thr), cosmic curated COSV10441
- K9R (p.Lys9Arg), gnomAD 20-37384177-CA-C, CADD 29.90
- K9N (p.Lys9Asn), gnomAD 20-37384180-G-T, REVEL 0.11, MetaLR 0.24
- D10N (p.Asp10Asn), gnomAD rs1251001677, REVEL 0.22, CADD 23.90
- D10Y (p.Asp10Tyr), gnomAD 20-37384181-G-T, REVEL 0.41, MetaLR 0.31
- D10D (p.Asp10Asp), gnomAD 20-37384183-T-C, CADD 5.52
- A11P (p.Ala11Pro), TOPMed rs1318197870, gnomAD rs1318197870
- A11T (p.Ala11Thr), TOPMed rs1318197870, gnomAD rs1318197870, REVEL 0.09, CADD 22.50
- A11V (p.Ala11Val), gnomAD rs1212841399, REVEL 0.11, CADD 22.30
- A11S (p.Ala11Ser), gnomAD 20-37384184-G-T, REVEL 0.12, MetaLR 0.19
- A11D (p.Ala11Asp), gnomAD 20-37384185-C-A, REVEL 0.29, MetaLR 0.20
- A11A (p.Ala11Ala), gnomAD 20-37384186-C-A, CADD 14.20
- S12G (p.Ser12Gly), cosmic curated COSV10651
- S12I (p.Ser12Ile), cosmic curated COSV10943, REVEL 0.17, CADD 23.90
- S12R (p.Ser12Arg), Ensembl rs2070408905, REVEL 0.14, CADD 22.20
- S12N (p.Ser12Asn), gnomAD 20-37384188-G-A, REVEL 0.10, MetaLR 0.24
- S12S (p.Ser12Ser), gnomAD 20-37384189-C-T, CADD 14.50
- Q13K (p.Gln13Lys), cosmic curated COSV10065
- Q13R (p.Gln13Arg), TOPMed rs1250842919, gnomAD rs1250842919, REVEL 0.15, CADD 22.50
- Q13Q (p.Gln13Gln), gnomAD 20-37384192-G-A, CADD 11.00
- Q13H (p.Gln13His), gnomAD 20-37384192-G-T, REVEL 0.21, MetaLR 0.24
- R14L (p.Arg14Leu), cosmic curated COSV10065, REVEL 0.37, CADD 25.20
- R14P (p.Arg14Pro), Ensembl rs2147049272
- R14W (p.Arg14Trp), NCI-TCGA Cosmic COSV6244, cosmic curated COSV62441, Ensembl rs2147049257, REVEL 0.43, CADD 24.80, Variant assessed as somatic; moderate impact.
- R14R (p.Arg14Arg), gnomAD 20-37384193-C-A, CADD 14.00
- R15C (p.Arg15Cys), cosmic curated COSV62439, Ensembl rs2147049292, REVEL 0.25, CADD 23.60
- R15H (p.Arg15His), Ensembl rs2070409016, REVEL 0.12, CADD 23.40
- R15S (p.Arg15Ser), gnomAD 20-37384196-C-A, REVEL 0.06, MetaLR 0.14
- R15L (p.Arg15Leu), gnomAD 20-37384197-G-T, REVEL 0.07, MetaLR 0.25
- R15P (p.Arg15Pro), gnomAD 20-37384197-G-C, REVEL 0.26, MetaLR 0.25
- R15R (p.Arg15Arg), rs1387141295, gnomAD 20-37384198-C-T, CADD 14.10
- R16C (p.Arg16Cys), Ensembl rs2147049327, REVEL 0.29, CADD 23.10
- R16H (p.Arg16His), NCI-TCGA Cosmic COSV6244, cosmic curated COSV62441, TOPMed rs2070409119, REVEL 0.20, CADD 23.30, Variant assessed as somatic; moderate impact.
- R16P (p.Arg16Pro), TOPMed rs2070409119
- R16Q (p.Arg16Gln), gnomAD 20-37384197-GCC-G, CADD 26.20
- R16S (p.Arg16Ser), gnomAD 20-37384199-C-A, REVEL 0.26, MetaLR 0.25
- R16L (p.Arg16Leu), gnomAD 20-37384200-G-T, REVEL 0.22, MetaLR 0.27
- R16R (p.Arg16Arg), gnomAD 20-37384201-C-T, CADD 15.30
- S17R (p.Ser17Arg), Ensembl rs2147049362, REVEL 0.35, CADD 25.10
- S17T (p.Ser17Thr), Ensembl rs2147049371
- S17G (p.Ser17Gly), gnomAD 20-37384202-A-G, REVEL 0.32, MetaLR 0.39
- S17N (p.Ser17Asn), gnomAD 20-37384203-G-A, REVEL 0.33, MetaLR 0.43
- S17I (p.Ser17Ile), gnomAD 20-37384203-G-T, REVEL 0.38, MetaLR 0.46
- L18L (p.Leu18Leu), rs2070409182, gnomAD 20-37384205-C-T, CADD 13.80
- L18P (p.Leu18Pro), gnomAD 20-37384206-T-C, REVEL 0.40, MetaLR 0.45
- E19G (p.Glu19Gly), Ensembl rs2147049408, REVEL 0.24, CADD 24.10
- E19Q (p.Glu19Gln), TOPMed rs1162867836
- E19K (p.Glu19Lys), gnomAD 20-37384208-G-A, REVEL 0.20, MetaLR 0.23
- E19* (p.Glu19Ter), gnomAD 20-37384208-G-T, CADD 38.00
- E19D (p.Glu19Asp), gnomAD 20-37384210-G-T, REVEL 0.11, MetaLR 0.13
- P20A (p.Pro20Ala), ExAC rs753143221, TOPMed rs753143221, gnomAD rs753143221, REVEL 0.13, CADD 18.20
- P20H (p.Pro20His), Ensembl rs2147049436
- P20S (p.Pro20Ser), cosmic curated COSV62440, REVEL 0.09, CADD 19.20
- P20T (p.Pro20Thr), gnomAD 20-37384211-C-A, REVEL 0.11, MetaLR 0.20
- P20L (p.Pro20Leu), gnomAD 20-37384212-C-T, REVEL 0.11, MetaLR 0.23
- P20P (p.Pro20Pro), rs1191370735, gnomAD 20-37384213-C-T, CADD 5.50
- A21D (p.Ala21Asp), Ensembl rs2070409442
- A21P (p.Ala21Pro), gnomAD rs367543238
- A21T (p.Ala21Thr), rs367543238, ClinGen CA226013, cosmic curated COSV62441, ClinVar RCV000084815, REVEL 0.14, CADD 0.00, not provided
- A21V (p.Ala21Val), Ensembl rs2070409442, REVEL 0.19, CADD 15.90
- A21S (p.Ala21Ser), gnomAD 20-37384214-G-T, REVEL 0.14, MetaLR 0.10
- A21A (p.Ala21Ala), rs761072453, gnomAD 20-37384216-C-G, CADD 4.89
- E22K (p.Glu22Lys), rs1416764320, TOPMed rs1416764320, gnomAD rs1416764320, REVEL 0.32, CADD 21.30, Variant assessed as somatic; moderate impact.
- E22* (p.Glu22Ter), gnomAD 20-37384217-G-T, CADD 36.00
- E22D (p.Glu22Asp), gnomAD 20-37384219-G-T, REVEL 0.17, MetaLR 0.15
- E22E (p.Glu22Glu), rs1182247021, gnomAD 20-37384219-G-A, CADD 9.24
- N23D (p.Asn23Asp), Ensembl rs2147049521
- N23S (p.Asn23Ser), ExAC rs764712270, gnomAD rs764712270
- N23T (p.Asn23Thr), ExAC rs764712270, gnomAD rs764712270, REVEL 0.17, CADD 8.37
- N23K (p.Asn23Lys), gnomAD 20-37384222-C-A, REVEL 0.10, MetaLR 0.16
- N23N (p.Asn23Asn), rs754332476, gnomAD 20-37384222-C-T, CADD 7.45
- V24G (p.Val24Gly), Ensembl rs2147049563
- V24M (p.Val24Met), cosmic curated COSV10651, Ensembl rs2070409753, REVEL 0.13, CADD 8.91
- V24L (p.Val24Leu), gnomAD 20-37384223-G-T, REVEL 0.08, MetaLR 0.15
- V24V (p.Val24Val), rs2147049575, gnomAD 20-37384225-G-A, CADD 5.76
- H25D (p.His25Asp), TOPMed rs1188439975, gnomAD rs1188439975, REVEL 0.34, CADD 21.80
- H25Y (p.His25Tyr), cosmic curated COSV62440, REVEL 0.17, CADD 20.50
- H25H (p.His25His), rs757703535, gnomAD 20-37384228-C-T, CADD 1.67
- H25Q (p.His25Gln), gnomAD 20-37384228-C-A, REVEL 0.22, MetaLR 0.21
- G26C (p.Gly26Cys), ExAC rs779676153, TOPMed rs779676153, gnomAD rs779676153, REVEL 0.27, CADD 20.60
- G26R (p.Gly26Arg), ExAC rs779676153, TOPMed rs779676153, gnomAD rs779676153, REVEL 0.25, CADD 10.80
- G26S (p.Gly26Ser), NCI-TCGA Cosmic COSV6244, cosmic curated COSV62441, Variant assessed as somatic; moderate impact.
- G26A (p.Gly26Ala), gnomAD 20-37384230-G-C, REVEL 0.14, MetaLR 0.18
- G26D (p.Gly26Asp), gnomAD 20-37384230-G-A, REVEL 0.26, MetaLR 0.19
- G26G (p.Gly26Gly), rs2147049619, gnomAD 20-37384231-C-A, CADD 1.00
- A27G (p.Ala27Gly), cosmic curated COSV10065
- A27P (p.Ala27Pro), TOPMed rs2070409976
- A27T (p.Ala27Thr), cosmic curated COSV62440, TOPMed rs2070409976, REVEL 0.08, CADD 12.60
- A27S (p.Ala27Ser), gnomAD 20-37384232-G-T, REVEL 0.06, MetaLR 0.15
- A27V (p.Ala27Val), gnomAD 20-37384233-C-T, REVEL 0.11, MetaLR 0.18
- A27D (p.Ala27Asp), gnomAD 20-37384233-C-A, REVEL 0.13, MetaLR 0.18
- G28S (p.Gly28Ser), ExAC rs750998052, gnomAD rs750998052, REVEL 0.13, CADD 13.70
- p.Gly28 Ala31del, gnomAD 20-37384228-CGGCG, CADD 17.40
- G28C (p.Gly28Cys), gnomAD 20-37384235-G-T, REVEL 0.30, MetaLR 0.19
- G28G (p.Gly28Gly), rs2147049683, gnomAD 20-37384237-C-T, CADD 4.40
- G29R (p.Gly29Arg), TOPMed rs367543239, REVEL 0.23, CADD 22.80
- G29V (p.Gly29Val), cosmic curated COSV10591, REVEL 0.20, CADD 23.20
- G29W (p.Gly29Trp), rs367543239, ClinGen CA226015, ClinVar RCV000084816, TOPMed rs367543239, REVEL 0.27, CADD 23.30
- G29G (p.Gly29Gly), gnomAD 20-37384240-G-T, CADD 6.74
- G30R (p.Gly30Arg), TOPMed rs2070410128
- G30A (p.Gly30Ala), gnomAD 20-37384237-CG-C, CADD 24.00
- G30S (p.Gly30Ser), gnomAD 20-37384241-G-A, REVEL 0.07, MetaLR 0.19
- G30C (p.Gly30Cys), gnomAD 20-37384241-G-T, REVEL 0.21, MetaLR 0.27
- G30D (p.Gly30Asp), gnomAD 20-37384242-G-A, REVEL 0.11, MetaLR 0.23
- G30V (p.Gly30Val), gnomAD 20-37384242-G-T, REVEL 0.10, MetaLR 0.21
- G30G (p.Gly30Gly), gnomAD 20-37384243-C-A, CADD 1.64
- A31T (p.Ala31Thr), gnomAD rs1437496392, REVEL 0.14, CADD 19.30
- A31V (p.Ala31Val), cosmic curated COSV10525, REVEL 0.17, CADD 19.60
- A31R (p.Ala31Arg), gnomAD 20-37384237-C-CG, CADD 24.40
- A31S (p.Ala31Ser), gnomAD 20-37384244-G-T, REVEL 0.12, MetaLR 0.11
- A31G (p.Ala31Gly), gnomAD 20-37384245-C-G, REVEL 0.18, MetaLR 0.14
- A31A (p.Ala31Ala), rs2147049736, gnomAD 20-37384246-T-C, CADD 12.60
- F32S (p.Phe32Ser), cosmic curated COSV10969, ExAC rs754705008, gnomAD rs754705008, REVEL 0.24, CADD 22.30
- F32L (p.Phe32Leu), gnomAD 20-37384247-T-C, REVEL 0.15, MetaLR 0.14
- F32C (p.Phe32Cys), gnomAD 20-37384248-T-G, REVEL 0.26, MetaLR 0.23
- F32F (p.Phe32Phe), gnomAD 20-37384249-C-T, CADD 10.50
- P33A (p.Pro33Ala), TOPMed rs1371352984, gnomAD rs1371352984, REVEL 0.12, CADD 18.60
- P33L (p.Pro33Leu), cosmic curated COSV62439, 1000Genomes rs2070410421, TOPMed rs2070410421, REVEL 0.16, CADD 23.20
- P33S (p.Pro33Ser), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10065, Variant assessed as somatic; moderate impact.
- P33P (p.Pro33Pro), rs780787481, gnomAD 20-37384252-C-T, CADD 7.36
- A34D (p.Ala34Asp), TOPMed rs1447509893
- A34P (p.Ala34Pro), 1000Genomes rs1288993928, TOPMed rs1288993928, gnomAD rs1288993928, REVEL 0.15, CADD 8.88, Uncertain significance, not specified
- A34S (p.Ala34Ser), 1000Genomes rs1288993928, TOPMed rs1288993928, gnomAD rs1288993928, REVEL 0.10, CADD 2.00, Uncertain significance
- A34T (p.Ala34Thr), rs1288993928, NCI-TCGA Cosmic COSV6243, cosmic curated COSV62439, 1000Genomes rs1288993928, REVEL 0.13, CADD 3.09, Uncertain significance
- A34V (p.Ala34Val), TOPMed rs1447509893, REVEL 0.12, CADD 15.10
- A34G (p.Ala34Gly), gnomAD 20-37384254-C-G, REVEL 0.15, MetaLR 0.26
- A34A (p.Ala34Ala), gnomAD 20-37384255-C-T, CADD 10.30
- S35A (p.Ser35Ala), cosmic curated COSV10888, gnomAD rs1232549534
- S35L (p.Ser35Leu), NCI-TCGA Cosmic COSV6244, cosmic curated COSV62441, REVEL 0.13, CADD 19.90, Variant assessed as somatic; moderate impact.
- S35P (p.Ser35Pro), gnomAD rs1232549534, REVEL 0.23, CADD 15.70
- S35W (p.Ser35Trp), gnomAD 20-37384257-C-G, REVEL 0.25, MetaLR 0.42
- S35S (p.Ser35Ser), gnomAD 20-37384258-G-T, CADD 4.14
- Q36H (p.Gln36His), gnomAD rs55962640, REVEL 0.14, CADD 22.20
- Q36* (p.Gln36Ter), gnomAD 20-37384259-C-T, CADD 36.00
- Q36K (p.Gln36Lys), gnomAD 20-37384259-C-A, REVEL 0.09, MetaLR 0.28
- Q36R (p.Gln36Arg), gnomAD 20-37384260-A-G, REVEL 0.11, MetaLR 0.22
- Q36L (p.Gln36Leu), gnomAD 20-37384260-A-T, REVEL 0.20, MetaLR 0.24
- Q36P (p.Gln36Pro), gnomAD 20-37384260-A-C, REVEL 0.24, MetaLR 0.22
- T37A (p.Thr37Ala), Ensembl rs911387445
- T37I (p.Thr37Ile), ExAC rs769523302, TOPMed rs769523302, gnomAD rs769523302, REVEL 0.25, CADD 25.60
- T37N (p.Thr37Asn), cosmic curated COSV10969, REVEL 0.24, CADD 23.60
- T37P (p.Thr37Pro), Ensembl rs911387445
- T37S (p.Thr37Ser), gnomAD 20-37384263-C-G, REVEL 0.18, MetaLR 0.49
- T37T (p.Thr37Thr), gnomAD 20-37384264-C-T, CADD 10.60
- P38L (p.Pro38Leu), ExAC rs777533514, gnomAD rs777533514, REVEL 0.28, CADD 28.30
- P38R (p.Pro38Arg), ExAC rs777533514, gnomAD rs777533514, REVEL 0.30, CADD 27.30
- P38T (p.Pro38Thr), TOPMed rs2070410985, REVEL 0.25, CADD 25.40
- P38H (p.Pro38His), gnomAD 20-37384266-C-A, REVEL 0.31, MetaLR 0.50
Public SRC analysis runs
- SRC analysis run — SRC (1,057 variants) — completed 2026-08-21